A Trial of SHR0410 Injection in Hemodialysis Participants.
Status:
Completed
Trial end date:
2019-11-08
Target enrollment:
Participant gender:
Summary
This is a multi-site study to evaluate the safety and pharmacokinetics of repeated doses of
IV SHR0410 in participants who are undergoing hemodialysis.